Insights Blog

DeciBio Consulting has released the fourth edition of its Oncology Liquid Biopsy Market Report, offering updated global estimates of how liquid biopsy technologies are being applied across clinical and pharmaceutical research settings.

We had the pleasure of speaking with Britton Jimenez, SVP of Sales and Marketing at Codexis, about the continued momentum in oligonucleotide therapeutics.

February’s healthcare activity was defined by pipeline‑focused acquisitions, AI‑enabled partnerships, and a broad reopening of the biotech IPO window across de‑risked immunology, oncology, and specialty indications.

New updates in the digital health landscape!

This report examines the rapidly growing MRD/monitoring landscape, highlighting the persistent challenges in assay standardization despite expanding trials, coverage, and test adoption and offering frameworks for data interpretation alongside defining meaningful measures of sensitivity to enable more informed, actionable, and equitable clinical use.

Next-generation tools, from spatial proteomics to high-plex affinity assays, are reviving proteomics and unlocking the proteome as a scalable layer of biology.